AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Pandolfino, MC Labarriere, N Tessier, MH Cassidanius, A Bercegeay, S Lemarre, P Dehaut, F Dreno, B Jotereau, F
Citation: Mc. Pandolfino et al., High-scale expansion of melanoma-reactive TIL by a polyclonal stimulus: predictability and relation with disease advancement, CANCER IMMU, 50(3), 2001, pp. 134-140

Authors: Fonteneau, JF Larsson, M Somersan, S Sanders, C Munz, C Kwok, WW Bhardwaj, N Jotereau, F
Citation: Jf. Fonteneau et al., Generation of high quantities of viral and tumor-specific human CD4+and CD8+T-cell clones using peptide pulsed mature dendritic cells, J IMMUNOL M, 258(1-2), 2001, pp. 111-126

Authors: Benlalam, H Labarriere, N Linard, B Derre, L Diez, E Pandolfino, MC Bonneville, M Jotereau, F
Citation: H. Benlalam et al., Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL): implications for immunotherapy, EUR J IMMUN, 31(7), 2001, pp. 2007-2015

Authors: Gervois, N Labarriere, N Le Guiner, S Pandolfino, MC Fonteneau, JF Guilloux, Y Diez, E Dreno, B Jotereau, F
Citation: N. Gervois et al., High avidity melanoma-reactive cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocytes on stimulation by peptide-pulsed melanoma cells, CLIN CANC R, 6(4), 2000, pp. 1459-1467

Authors: Moreau-Aubry, A Le Guiner, S Labarriere, N Gesnel, MC Jotereau, F Breathnach, R
Citation: A. Moreau-aubry et al., A processed pseudogene codes for a new antigen recognized by a CD8(+) T cell clone on melanoma, J EXP MED, 191(9), 2000, pp. 1617-1623

Authors: Pellat-Deceunynck, C Mellerin, MP Labarriere, N Jego, G Moreau-Aubry, A Harousseau, JL Jotereau, F Bataille, R
Citation: C. Pellat-deceunynck et al., The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressedby human myeloma cells, EUR J IMMUN, 30(3), 2000, pp. 803-809

Authors: Valmori, D Fonteneau, JF Valitutti, S Gervois, N Dunbar, R Lienard, D Rimoldi, D Cerundolo, V Jotereau, F Cerottini, JC Speiser, DE Romero, P
Citation: D. Valmori et al., Optimal activation of tumor-reactive T cells by selected antigenic peptideanalogues, INT IMMUNOL, 11(12), 1999, pp. 1971-1979

Authors: Ibisch, C Gallot, G Vivien, R Diez, E Jotereau, F Garand, R Vie, H
Citation: C. Ibisch et al., Recognition of leukemic blasts by HLA-DPB1-specific cytotoxic T cell clones: a perspective for adjuvant immunotherapy post-bone marrow transplantation, BONE MAR TR, 23(11), 1999, pp. 1153-1159

Authors: Valmori, D Gervois, N Rimoldi, D Fonteneau, JF Bonelo, A Lienard, D Rivoltini, L Jotereau, F Cerottini, JC Romero, P
Citation: D. Valmori et al., Diversity of the fine specificity displayed by HLA-A0201-restricted CTL specific for the immunodominant Melan-A/MART-1. (vol 161, pg 6956, 1998), J IMMUNOL, 163(2), 1999, pp. 1093-1093

Authors: Choudhary, A Kurt, RA Goret, F Moreau, A Diez, E Urba, WJ Jotereau, F Pourcel, C
Citation: A. Choudhary et al., Mutated cytochrome b as a determinant of a new monoclonal antibody (H8.98)on renal carcinoma cell lines recognized by a V gamma 3V delta 1(+) T-cellclone, INT J CANC, 82(4), 1999, pp. 562-568

Authors: Valmori, D Gervois, N Rimoldi, D Fonteneau, JF Bonelo, A Lienard, D Rivoltini, L Jotereau, F Cerottini, JC Romero, P
Citation: D. Valmori et al., Diversity of the fine specificity displayed by HLA-A0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptide, J IMMUNOL, 161(12), 1998, pp. 6956-6962
Risultati: 1-11 |